January 28, 2013 at 17:48 PM EST
Zoetis IPO Will Test Market's Appetite For Big Deals
It's been a while since anyone tried to raise $2 billion on the IPO market. But Zoetis is not your typical IPO. The company comprises the animal-health business of giant pharma Pfizer (PFE), which has been selling off some of its non-core divisions to make up for its lost blockbuster drugs. With more than $4 billion in annual sales, Zoetis is the global leader in its $22 billion industry. And the recent friendly receptions for the IPOs of Norwegian Cruise Line (NCLH)
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here